RecruitingNCT03973671
Prospective Sample Collection for Cancer of Bladder
Flemish Prospective Clinical and Pathological Database for Urothelial Cancer
Sponsor
Universitaire Ziekenhuizen KU Leuven
Enrollment
300 participants
Start Date
May 29, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of the Flemish Databank for Urothelial Cancer is to collect clinical and pathological data of patients treated for urothelial cancer (UC).
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Plain Language Summary
Simplified for easier understanding
This study collects tissue and clinical data from patients undergoing surgery or procedures for bladder cancer. The goal is to better understand the disease and improve future diagnosis and treatment.
**You may be eligible if...**
- You are between 18 and 90 years old
- You are scheduled for a bladder cancer procedure such as TURBT (tumor removal via scope), cystectomy (bladder removal), nephroureterectomy, or biopsy
- You consent to have your clinical and tissue data collected
**You may NOT be eligible if...**
- You do not give consent for data collection
- Other reasons as determined by the research team
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03973671
Related Trials
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
NCT0722248814 locations
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
NCT0696057759 locations
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
NCT0561473984 locations
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT04389632158 locations
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380281 locations